Halitosis Clinical Trial
Official title:
Bad Breath Response to Tongue Scraper and Rinses, a Double-blind, Randomized, Parallel Group Clinical Trial.
Medical center personnel were screened organoleptically for bad breath by 2 investigators using Rosenberg scale 0-5, and measurement of breath sample in portable gas chromatograph. With a threshold score of 2 or more, or 75parts per billion(ppb) hydrogen sulfide(H2S), subjects invited to enter clinical trial of the mechanical effect of daily tongue scraping with the adjunctive use of 0.12% chlorhexidine gluconate mouthwash or 0.1% stabilized chlorine dioxide mouthwash. Subjects randomly assigned in double-blind trial for one week. The null hypothesis is there will be no difference between the two rinses as adjuncts to tongue scraping.
Subjects in trial had oral and periodontal exam and scored the Ramfjord teeth(#3, 9, 12, 19, 25, 28) for Plaque Index(PlI), Gingival Index(GI), probing depth (PD), recession. A tongue coating index is scored and sample of coating on dorsum taken for culture of total viable count and percentage of black sulfide-producing colonies on anaerobe agar with lead acetate added. Subjects given hygiene instruction and instruction on use of scraper, then rinse with 20ml assigned mouthwash 30sec. Breath assessed by organoleptic means and mouth air sample concentration of hydrogen sulfide, methyl mercaptan in portable gas chromatograph at 0, 1, 2, and 4 hours. Subjects use scraper and mouthwash twice daily for one week and return for final exam. ;
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04279106 -
Effect of Single Rinsing With Three Different Types of Mouthwash on VSC Levels in Morning Breath
|
N/A | |
Completed |
NCT05413382 -
Effect of an Investigational Lozenge (Biofresh® 4plus) Versus Placebo Control on Oral Malodor (Intra-Oral Halitosis)
|
N/A | |
Completed |
NCT04914208 -
Effect of Wearing Face Masks on Salivary Parameters and Halitosis
|
N/A | |
Completed |
NCT05524948 -
A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With Gingivitis
|
N/A | |
Completed |
NCT02113137 -
Oral Hygiene Procedures on Reduction of Oral Malodor
|
Phase 4 | |
Completed |
NCT02689297 -
Three Different Oral Hygiene Regimes on Three Volatile Sulfur Compounds
|
Phase 4 | |
Completed |
NCT01046812 -
Halitosis Devised Questionnaire Evaluating a New Treatment
|
N/A | |
Withdrawn |
NCT02665780 -
Assessing the Effect of Periodontal Debridement, Tongue Cleaning and Mouth Rinsing for the Treatment of Oral Malodour
|
N/A | |
Completed |
NCT01948349 -
Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient
|
N/A | |
Recruiting |
NCT02007993 -
Photodynamic Therapy in Adolescents Halitosis
|
N/A | |
Completed |
NCT01269957 -
Halitosis and Mouth Breathing in Children
|
N/A | |
Completed |
NCT04632004 -
Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health
|
N/A | |
Completed |
NCT04998617 -
Effects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis
|
N/A | |
Not yet recruiting |
NCT00875927 -
Effects of Breezy Candy on Halitosis
|
Phase 1/Phase 2 | |
Completed |
NCT01139073 -
A New Portable Monitor for Measuring Odorous Compounds in Oral, Exhaled and Nasal Air
|
N/A | |
Completed |
NCT03196648 -
Randomized Trial of a Gum Health Formulation
|
N/A | |
Recruiting |
NCT03346460 -
Effect of Photodymamic Therapy With Urucum and LED in the Reduction of Halitosis
|
Phase 2 | |
Completed |
NCT03468595 -
Clinical Evaluation of Some Local Antimicrobial Agents' Adjunctive Effects On Periodontal Parameters and Halitosis
|
N/A | |
Completed |
NCT02794766 -
Inulin and S. Salivarius Reduce Halitosis
|
Phase 2 | |
Completed |
NCT02628938 -
Effect of Miswak and Miswak Extract on Oral Malodor
|
Phase 2 |